FMP
Helius Medical Technologies, Inc.
HSDT
NASDAQ
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
0.91 USD
0.458 (50.33%)
About
ceo
Mr. Dane Carl Andreeff
sector
Healthcare
industry
Medical - Devices
website
https://heliusmedical.comexchange
NASDAQ
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
CIK
0001610853
ISIN
US42328V8019
CUSIP
42328V504
Address
642 Newtown Yardley Road
Phone
215 944 6100
Country
US
Employee
22
IPO Date
Jun 27, 2014
Key Executives
